Clinical Data Beam posts positive data on base editing treatment for AATD BioPharma DiveUpdated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins in a small study.Clinical DataRare DiseaseRead full story pharminent March 25, 2026 (Last updated: March 26, 2026) BioPharma Dive Updated data showed the biotech’s approach to the rare lung and liver condition helped restore functional protective proteins in a small study. Clinical DataRare DiseaseRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sarepta sees early success with RNAi drugs from ArrowheadNext: Maze tumbles despite positive data for kidney disease drug Related Stories Clinical Data AstraZeneca, Ionis drug fails big heart disease study in major setback pharminent July 9, 2026 Clinical Data Roche’s KRAS drug tops its rivals in lung cancer trial pharminent July 2, 2026 Clinical Data EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s pharminent July 1, 2026
